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Mortality surveillance and cause of death data are instrumental in improving health, identifying diseases and conditions that cause 
a high burden of preventable deaths, and allocating resources to prevent these deaths. The Child Health and Mortality Prevention 
Surveillance (CHAMPS) network uses a standardized process to define, assign, and code causes of stillbirth and child death (<5 years 
of age) across the CHAMPS network. A  Determination of Cause of Death (DeCoDe) panel composed of experts from a local 
CHAMPS site analyzes all available individual information, including laboratory, histopathology, abstracted clinical records, and 
verbal autopsy findings for each case and, if applicable, also for the mother. Using this information, the site panel ascertains the un-
derlying cause (event that precipitated the fatal sequence of events) and other antecedent, immediate, and maternal causes of death 
in accordance with the International Classification of Diseases, Tenth Revision and the World Health Organization death certificate. 
Development and use of the CHAMPS diagnosis standards—a framework of required evidence to support cause of death determina-
tion—assures a homogenized procedure leading to a more consistent interpretation of complex data across the CHAMPS network. 
This and other standardizations ensures future comparability with other sources of mortality data produced externally to this pro-
ject. Early lessons learned from implementation of DeCoDe in 5 CHAMPS sites in sub-Saharan Africa and Bangladesh have been 
incorporated into the DeCoDe process, and the implementation of DeCoDe has the potential to spur health systems improvements 
and local public health action.
Keywords.  mortality review; cause of death; vital records; CHAMPS; data management.
Accurate determination of cause of death is the foundation of 
mortality surveillance. The understanding of how and why chil-
dren die informs prevention efforts and guides interventions to 
save lives. Mortality reviews are recognized as important tools 
in understanding cause of death and prioritizing opportun-
ities for intervention in high-resource countries [1, 2]. Yet, in-
sufficient mortality reviews are conducted in areas where they 
would be most needed—that is, where the highest child mor-
tality is currently happening [3].
Despite immense strides in the reduction of global under-5 
mortality, in 2017 an estimated 5.4 million children died be-
fore their fifth birthday and >2.5 million stillbirths occurred. 
These deaths and stillbirths are disproportionally concentrated 
in low-resource settings in sub-Saharan Africa and South Asia 
[4]. Many occur at home without the child ever seeing a health-
care provider. Even when a child is brought to care and subse-
quently dies in a healthcare setting, cause of death often remains 
unknown or nonspecific. Clinicians may suspect a condition but 
may lack the clinical or laboratory resources to confirm their di-
agnosis with the specificity needed to maximize prevention—for 
example, the pathogen(s) responsible for pneumonia in a child, 
or for a maternal chorioamnionitis leading to stillbirth.
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Even when the conditions causing death are known, these 
are often inaccurately or inconsistently recorded on a death 
certificate. Vital records, including death certificates, exist for 
less than half of the world’s population [5]. In an assessment 
of global typology of civil registration and vital statistics, the 
areas of the world with the highest child mortality often have 
the poorest performance or no data available [6]. The central 
aim of the Child Health and Mortality Prevention Surveillance 
(CHAMPS) network is to fill the gaps in the global under-
standing of specific causes of under-5 mortality in areas with 
under-5 mortality >50 per 1000 live births.
Here, we describe the standardized methods, known collec-
tively as the Determination of Cause of Death (DeCoDe) pro-
cess, used to define, code, and assign causes of under-5 child 
death and stillbirth across the CHAMPS network.
OVERVIEW OF DECODE PROCESS
Stillbirths and under-5 child deaths from catchment areas in 
the CHAMPS network that have parental consent (see Salzberg 
et  al in this supplement) undergo postmortem specimen col-
lection through a minimally invasive tissue sampling (MITS) 
procedure (see Ordi et al in this supplement) to collect tissue 
for histopathology and detection of pathogens using molec-
ular techniques and immunohistochemistry staining, as well 
as extensive diagnostic testing. Prior to the MITS procedure, 
photos and anthropometric measurements are obtained. For 
each deceased case, CHAMPS sites generate a robust dossier 
of MITS, histopathology, and laboratory analyses results, along 
with clinical records (for the deceased child and, if relevant, the 
mother) and verbal autopsy, to accurately determine cause of 
death. A panel of experts, known as the DeCoDe panel, com-
prised by a variety of clinical and laboratorial expertise, thor-
oughly analyzes and reviews the compiled data in the local 
context to propose, in light of all available evidence, the most 
plausible explanation for the underlying cause of death and the 
fatal sequence of events. This in-depth review is conducted at 
each CHAMPS surveillance site. Figure 1 outlines the DeCoDe 
process.
DEVELOPMENT AND PILOT OF DECODE PROCESS
The CHAMPS DeCoDe panel process was developed as a meth-
odology to review data collected through systematic CHAMPS 
surveillance activities, elucidate the causal chain of events 
leading to death, and systematically assign cause of death using 
Figure 1. Overview of the determination of cause of death process. Abbreviations: CHAMPS, Child Health and Mortality Prevention Surveillance; DeCoDe, Determination 
of Causes of Death panel; ICD-10, International Classification of Diseases, Tenth Revision.
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standard practices. The DeCoDe process is modeled after death 
investigation and review panels: There are examples of death 
investigation and review in high-income settings that use sim-
ilar approaches [1, 7–9]. Throughout the design and imple-
mentation of the DeCoDe process, advisors involved with these 
reviews were consulted to design an efficient and robust proce-
dure, which could be utilized across all CHAMPS sites.
The DeCoDe panel is composed of clinicians (obstetricians 
and pediatricians with subspecialty expertise in fields such as 
neonatology and infectious diseases), microbiologists, patholo-
gists, and medical epidemiologists or other public health spe-
cialists. Individual panelists review case information presented 
in a standardized data packet. After their review, panelists re-
cord their cause of death determinations on a standard case re-
port form, in accordance with the World Health Organization 
(WHO) death certificate, the International Classification of 
Diseases, Tenth Revision (ICD-10) [10], and the WHO applica-
tion of ICD-10 to deaths during the perinatal period (ICD-PM) 
[11]. A  CHAMPS-specific form, modeled from preexisting 
similar documents, captures the immediate (disease or condi-
tion which directly preceded or directly led to death) and the 
comorbid and underlying (disease or injury that initiated the 
train of events leading directly to death) causes of death; a series 
of other useful information is collected such as the duration of 
each component of the chain of events, the certainty attributed 
to each diagnosis according to the available results, the utility 
of every data source for each diagnosis, and the recommenda-
tions issued by the panel should they think this death was pre-
ventable. For perinatal deaths, this form also includes maternal 
factors that precipitate or indirectly contribute to the fatal out-
come. If panelists submit their individual determinations prior 
to the panel meeting, a case manager assesses the level of con-
sensus among individual panel members regarding the cause of 
death determinations. The case manager prioritizes cases with 
lower concordance for discussion at the full panel meeting to 
allow for more time for discussion on these cases than on those 
cases with higher concordance.
During the full panel meeting, a case summary is presented 
and then the case is opened up for discussion. The panel re-
cords the group’s cause of death determination on a standard-
ized group case report form similar to the individual form, and 
the level of consensus for the determined causes is recorded 
as unanimous, majority, or no consensus. If consensus is not 
reached, the case manager determines if any cause of death is 
recorded or if the case remains undetermined.
Simultaneous with the CHAMPS DeCoDe process develop-
ment, a pre-CHAMPS MITS pilot study took place in South 
Africa (see Madhi et al in this supplement). This study inves-
tigated deaths in children <12  years old and stillbirths from 
a health facility and collected similar but slightly more lim-
ited data compared to the full CHAMPS protocol. The pre-
CHAMPS South African MITS study obtained clinical data 
(both child and maternal), microbiologic culture and PCR from 
blood, cerebrospinal fluid, rectal swab, lung, and liver (only cul-
ture), and histopathology on brain, liver, and lung; verbal au-
topsy interviews were not performed. Prior to completion of 
this study, an external pilot panel through the CHAMPS pro-
gram office was convened to review a subset of these cases and 
to test and adapt CHAMPS DeCoDe methodology. Volunteer 
panel members—pediatricians, pathologists, microbiologists, 
and epidemiologists—were recruited and trained on death cer-
tification and elementary ICD-10 codes and rules. Panelists re-
viewed both perinatal and nonperinatal cases and followed the 
proposed DeCoDe method for 2 panel discussions. In addition, 
at the end of the study a larger international panel was convened 
in South Africa to review and adjudicate the cause of deaths for 
all of the cases enrolled.
The CHAMPS DeCoDe process was refined through les-
sons learned from this pilot panel experience. Key revisions 
included making optional the prepanel documentation of indi-
vidual review results, inclusion of all cases for full panel discus-
sion regardless of individual review concordance, refinement of 
standard levels of certainty for listing a diagnosis, development 
of additional guidance to standardize interpretation of data, 
and identification of additional priority areas for training future 
CHAMPS panelists, including medical death certification and 
classification using ICD-10 and ICD-PM.
DEVELOPMENT OF DIAGNOSIS STANDARDS
Diagnosis standards for DeCoDe were developed to standardize 
the approach of local panelists in assigning and coding cause of 
death across diverse CHAMPS surveillance sites and DeCoDe 
panels. In general, these standards outline how to apply spe-
cific CHAMPS clinical and laboratory findings to the diagnoses 
of conditions contributing to mortality in children and link 
each diagnosis to its corresponding ICD-10 code in accord-
ance with international standards for mortality surveillance. In 
addition, they detail the process of assigning 3 possible levels 
of certainty to each diagnosis based on the completeness and 
specificity of available data substantiating the diagnosis. The 
current CHAMPS Diagnosis Standards (https://champshealth.
org/protocols/diagnosis-standards-decode/) include diagnoses 
that were selected based on several factors including the specific 
pathogens in the CHAMPS diagnostic array, a list of common 
causes of neonatal and pediatric death from the Global Burden 
of Disease Study, and conditions in ICD-PM known to cause 
death in the perinatal period. General standards for level of cer-
tainty for diagnosis of a condition were adapted from Population 
Health Metrics Research Consortium Neonatal and Child Gold 
Standard Diagnoses (Table 1) [12]. Importantly, the diagnosis 
standards have been conceived as a “living document,” thus 
incorporating on an annual basis additional diagnoses based on 
the lessons learned from their ongoing use.
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While the guidelines in Table 1 provide a general framework 
for the consideration of all diagnoses, they have some limita-
tions. The level of certainty for each condition does not indi-
cate causality—a more complicated assessment based on host 
and other factors—but instead indicates certainty for the diag-
nosis of a particular condition [13]. The standards cannot elu-
cidate the temporality of events leading to death—the causal 
chain must be organized on a case-by-case basis in accord-
ance with clinical judgment and ICD-10 coding standards, 
and through a consensus-seeking process part of the DeCoDe 
meetings. In addition, the broadly ranging clinical conditions 
inherent in CHAMPS cases do not all fit into this framework. 
For some causes of death (eg, witnessed injuries and poison-
ings), CHAMPS laboratory tests are not required or available 
to confirm the diagnosis. Moreover, the significance of many 
CHAMPS data elements—such as laboratory findings or ab-
stracted clinical symptoms—is subject to interpretation.
Panelists’ ability to apply these standards depends on the na-
ture and completeness of data for any individual case. In some 
cases, laboratory findings are inconclusive or do not exist so that 
the only pertinent data derive from clinical record abstractions. 
In other cases, the highly sensitive laboratory results detect a 
number of pathogens that may not necessarily be all patho-
genic, whereas in other cases the available data are insufficient 
to assign cause. For some cases, pathological findings are spe-
cific for a cause of death that is discordant with an antemortem 
diagnosis documented in the clinical record. For these types of 
cases, panelists must consider the entire picture and give more 
weight to the objective rather than subjective data elements 
[14]. While these standards do not substitute the clinical and 
pathological judgment, they do serve as a standard framework 
for interpreting the case-specific CHAMPS data and offer some 
objective criteria that inform the inclusion or exclusion of con-
ditions in the causal chain.
The CHAMPS Diagnosis Standards for specific conditions 
(Figure 2) were developed through refinement and applica-
tion of the general guidelines in Table 1 to specific diagnoses 
through a multistep process. These included (1) review of ex-
isting mortality surveillance or clinical management case def-
initions from internationally accepted bodies (ie, Centers for 
Disease Control and Prevention [CDC], Brighton Collaboration 
Neonatal Infections Working Group, Population Health Metrics 
Resource Consortium, American College of Obstetrics and 
Gynecology), as well as individual disease-specific reports; (2) 
adaptation of these ideal “case definitions” to “diagnosis stand-
ards” based on practical consideration of the clinical abstrac-
tion, verbal autopsy, and laboratory data available to CHAMPS 
DeCoDe panels; (3) refinement of each standard based on 
input from subject matter experts (SMEs) at the CDC, Emory 
University, and across the CHAMPS network; and (4) further 
refinement through application to cases from the South Africa 
pre-CHAMPS pilot with input from additional local site and in-
ternational SMEs (see Acknowledgments). The diagnosis stand-
ards will be updated with additional conditions and revised 
based on input from local panels and international SMEs on an 
ongoing basis. While the current diagnosis standards apply to 
common causes of death for neonates, infants, and children as 
well as some causes of stillbirth, additional standards are under 
development to provide more guidance on causes of stillbirth 
and maternal factors contributing to stillbirth and neonatal 
mortality.
DECODE DATA MANAGEMENT, QUALITY CONTROL, 
AND RESULTS GENERATION
Data collection, management and assimilation into a uniform 
case packet usable by DeCoDe panelists posed a unique chal-
lenge for the CHAMPS network. Information related to each 
case may include >120 clinical and molecular laboratory results, 
narrative and discrete pathology diagnoses and findings, and 
thousands of discrete data fields from clinical record abstrac-
tions and verbal autopsy, as well as many documents, photos, 
and pathology slide images (Table 2). Moreover, housing for 
primary data must be hosted in countries where CHAMPS op-
erates to minimize privacy and confidentiality concerns for case 
subjects and families and to comply with host country regula-
tions and laws. Names and other identifying information not 
essential for execution of the program must be removed from 
data before submission to the central CHAMPS global data 
repository.
Local data management capacity varies across the initial 
consortium of 5 CHAMPS surveillance sites implementing 
MITS and DeCoDe. However, all have sufficient capacity to 
host primary data collection. To reduce DeCoDe data manage-
ment complexity at sites and to ensure standardization across 
Table 1. General Guidelines for Assigning Level of Certainty for Conditions Affecting Stillbirths, Infants, and Children
Level 1 Level 2 Level 3
Diagnosis of a condition with the highest level of certainty pos-
sible for that condition, consisting of (1) highly specific patho-
logical findings or (2) a CHAMPS laboratory test with specific 
findings and medically observed and documented/clinically 
observed appropriate illness sign(s).
Diagnosis of a condition with a high level of 
certainty, consisting of (1) medically observed 
and documented appropriate illness sign(s) to 
support the diagnosis or (2) a CHAMPS labora-
tory test with specific findings and supporting 
symptoms reported by verbal autopsy.
Conditions that would be considered 
for diagnosis (ie, from verbal autopsy 
data alone) but do not meet level 1 or 
2 criteria.
Abbreviation: CHAMPS, Child Health and Mortality Prevention Surveillance.
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the CHAMPS network, case management and DeCoDe packet 
generation are supported via the CHAMPS Data Management 
Portal (CDMP) web application hosted by the CHAMPS 
Program Office (PO) at Emory University. The DeCoDe packet 
is a consolidated document that contains all of the data for each 
case presented as reports for each data type and source.
Figure 2. Diagnosis standard examples. The full document can be found https://champshealth.org/protocols/. Neonatal death and stillbirth refer to the type of Child Health 
and Mortality Prevention Surveillance case for which this standard would be used. Abbreviations: CMV, cytomegalovirus; CSF, cerebrospinal fluid; ICD-10, International 
Classification of Diseases, Tenth Revision; ND, neonatal death; PCR, polymerase chain reaction; RDS, respiratory distress syndrome; SB, stillbirth; TAC, TaqMan Array Card; 
VA, verbal autopsy; WHO, World Health Organization.
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Sites collect primary data using tools provided by the 
CHAMPS Program Office or their own systems for collec-
tion. The tools for primary data collection supported include 
Open Data Kit (Nafundi) for verbal autopsy and the Research 
Data Capture (REDCap) system (Vanderbilt University) for all 
other data. Data are extracted from local systems and submitted 
weekly to the global repository via a CDMP upload page.
As case data accumulate, site and PO staff collaborate on a 
continuous data quality process that results in high-quality cu-
mulative information being available on each case prior to gen-
eration of DeCoDe packets for panel review. Sites and PO staff 
iteratively track data quality progress throughout the case data cu-
ration process with the application of a combination of site- and 
PO-provided tools, reports, and queries. This process involves data 
entry validations, data quality scripts/reports that may be imple-
mented by the sites prior to weekly transmissions, automated file 
validation at the time of submission, and data validation scripts 
and reporting applied within the PO system. Because this process 
is applied throughout the active accumulation of data rather than 
retrospectively at the comprehensive submission of information, 
it enables higher-quality data within the necessary time targets.
The primary tool for case management and final DeCoDe 
packet generation is the MITS case management component of 
the CDMP. This component provides sites and PO staff with a 
listing of MITS cases that can be filtered and sorted and allows 
a user to select a specific case to view in detail. Site case man-
agers can manage cases for their site while PO case managers 
can view and manage cases across the network. The detail view 
lists a set of reports that users can view or download as a case 
proceeds through the workup and data become available. Each 
of the reports is compiled into a DeCoDe packet when case data 
collection and data quality cycles are complete.
At the time of DeCoDe packet generation, a packet version 
identifier and associated date/time of creation are recorded in 
the CDMP database. The packet version identifier is also in-
cluded on the DeCoDe packet provided to panelists and on 
final cause of death determinations submitted by the site after 
the DeCoDe panel has completed its deliberations. The version 
identifier and associated date enable the generation of a case-
level data packet with the most up-to-date information: records 
dated on or before the packet version date are extracted from the 
CDMP repository. The packet version identifier format is the 
concatenation of the case identifier and a 2-part version number 
(eg, XXAA00001_01_01). The versioning system was designed 
to support minor and major versions for packets, which occur 
frequently and rarely, respectively. The minor version supports 
generating multiple packets with newly updated information 
prior to a DeCoDe panel, whereas the major version links the 
underlying data and DeCoDe causes of death to a subsequent 
panel or process, which will produce an entirely separate cause 
of death determination. This latter situation may occur infre-
quently, for example, when new data become available and re-
assessing a case is necessary. In addition to the cause of death 
determinations made by the panel described above collected 
on a standard DeCoDe results form, the key data elements that 
were critical in each determination are also recorded. The panel 
also assesses whether the death in the individual case was pre-
ventable and records the public health actions recommended to 
Table 2.  Child Health and Mortality Prevention Surveillance Data Types and Sources
Data Type or Source Specific Content Obtained
Demographic Age, sex, date of birth, date of death, gestational age, and birth weight
Clinical records Maternal clinical data including antenatal consultations, delivery, and postpartum information
Child clinical data including antemortem diagnostics found in medical records and longitudinal informa-
tion on vaccination and growth history
Verbal autopsy Caregiver report of signs, symptoms, and narrative of fatal events 
MITS procedure Specimens collected (blood, CSF, NP swab, rectal swab/stool, and tissue biopsies)
 Photographs of face, full body, fingers, and any gross lesions or findings
Anthropometric measurements: head circumference, length, mid-upper arm circumference
Pathology Histology of postmortem biopsies (liver, lung, heart, brain, bone marrow) 
Placenta histology (if applicable)
 Immunohistochemistry 
Tissue PCR
Postmortem diagnostics Microbiology culture (blood, CSF)
Molecular PCR by TaqMan Array Cards (see Diaz et al in this supplement) (blood, CSF, stool, NP swab, 
lung tissue) 
 HIV PCR testing
TB PCR testing (lung tissue, stool)
 Malaria testing (thin and thick smears, rapid diagnostic tests)
DeCoDe panel outcomes Immediate cause of death, comorbid conditions, underlying cause of death; level of certainty, preventa-
bility, recommendations for public health action
Abbreviations: CSF, cerebrospinal fluid; DeCoDe, Determination of Causes of Death; HIV, human immunodeficiency virus; MITS, minimally invasive tissue sampling; NP, nasopharyngeal; 
PCR, polymerase chain reaction; TB, tuberculosis.
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prevent future deaths. When sites submit DeCoDe results to the 
CDMP repository, the packet version identifier on each case is 
matched to the active packet version identifier in the system. If 
an unknown or inactive packet version identifier is submitted, 
an error is generated and the PO follows up with the site. By 
design, the matching of the packet version identifier ensures the 
DeCoDe determinations submitted were based on the packet 
of information the panel reviewed. The final curation step for 
all case data submitted to the CDMP is a review of adherence 
to ICD-10 coding methodology and diagnosis standards. The 
DeCoDe results for each cause determination are reviewed in-
dividually to ensure the proper ICD-10 code was applied. If an 
incorrect code was assigned, the site is notified of the correct 
code and requested to change it in the database and resubmit 
results. Once this review is finished, the case is marked as 
complete.
DECODE STANDARDIZATION AND QUALITY 
ASSURANCE PROCESS
Diagnosis standards and centrally generated data packets are 2 
critical aspects of DeCoDe standardization across the CHAMPS 
network. In addition, the CHAMPS PO provides standard training 
to all site panelists on the WHO International Form of Medical 
Certificate of Cause of Death, the classification system, and general 
usage rules and coding principles following ICD-10 and ICD-PM.
A quality assurance process reviews how DeCoDe panels 
from each of the diverse CHAMPS settings apply the diag-
nosis standards to determine cause of death, with the aim of 
establishing intersite diagnostic reproducibility and concord-
ance across panels. On a regular basis (initially annually) a small 
subset (1–4) of cases from each study site is selected and shared 
across the network. Sites review these external cases during a 
regular panel meeting, and the results are collected centrally 
and analyzed for concordance across the network. The scoring 
for the concordance is outlined in Table 3. The concordance re-
sults will be used to identify areas needing retraining, revisions 
to the diagnosis standards, or process method modifications 
that will improve standardization across the network.
As a second facet of the quality assurance process, CHAMPS 
convenes in-person cross-network review of select CHAMPS 
cases with participants from each of the site panels and invited 
SMEs. These reviews provide fertile ground for cross-network 
in-person discussion on challenging aspects of incorporating 
all sources of evidence, interpreting CHAMPS data, and 
elucidating the causal chain. These panels will also introduce 
external SMEs to the DeCoDe process, highlight the impor-
tance of local panel insights, and generate discussion around 
cross-site themes that emerge. Local site teams are then able to 
compare data-to-action strategies on prevention efforts—from 
the household level at family follow-up to the community, hos-
pital, and larger spheres.
On an ongoing basis, CHAMPS refines the DeCoDe process 
and supporting standards to reflect lessons learned through 
the cross-network case sharing and in-person review processes 
with the goal of ensuring consistent application of data toward 
accurate cause of death determination across sites. If procedural 
changes occur (ie, addition of different types of specimens), 
methods, standards, and trainings to local sites will be adjusted 
and updated accordingly.
DISCUSSION
Currently, most vital registration in low- and middle-income 
countries (LMICs) has relied on health system records or verbal 
autopsies. CHAMPS provides a unique opportunity to supple-
ment verbal autopsies with detailed clinical, histological, and mi-
crobiological data to more accurately determine cause of death 
and to validate verbal autopsy algorithms. The challenge is to de-
velop standardized procedures to collate and interpret the data to 
provide high-quality determinations that mean the same thing 
across sites and ultimately can form the basis of sustainable and 
improved cause of death data that can be used by countries for 
actions to prevent under-5 mortality. The core elements of these 
Table 3.  Consensus Definitions for Child Health and Mortality Prevention Surveillance Quality Assurance Process
Consensus Definition
Complete consensus Complete consensus on Part I of the death certificate (all causes in the chain of events leading to death and the se-
quence of these causes) from all sites/panels
Key element consensus • Consensus on immediate and underlying causes of death with variations only in sequence of events
• Differences in cause of death assignment at the fourth ICD-10–coded digit with the first 3 digits matching
 • Different microbial etiologies selected in an infectious cause of death with >2 contributing microbes selected by the 
local panel
• Differences in final selection of specific suspected congenital anomaly if both anomalies are in the same organ 
system
 • Differences in the use of prematurity and low birth weight codes OR extreme prematurity and extremely low birth 
weight codes
Partial consensus Consensus with immediate or underlying causes of death
Nonconsensus No consensus with immediate or underlying causes
Abbreviation: ICD-10, International Classification of Diseases, Tenth Revision.
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standardized procedures in DeCoDe are utilizing ICD-10 and 
ICD-PM rules and coding, the diagnosis standards, quality data 
management and control, and the quality assurance procedures.
While there are limitations intrinsic to all death review pro-
cesses, coordination of DeCoDe processes across the varied 
CHAMPS sites and within LMIC settings poses some addi-
tional challenges. Preparing for and conducting DeCoDe panels 
is a time- and labor-intensive process both from the program-
matic perspective and for panelists. At CHAMPS sites, some 
local DeCoDe panelists fulfill critical clinical, laboratory, and 
public health roles with intensive workloads in their respec-
tive resource-limited settings. However, as DeCoDe panel dis-
cussions focus not just on determination of cause of death but 
on lessons learned, the process allows participants to address 
system failures and improve care for future patients—to con-
sider ways to immediately turn data into action and save lives 
both at facilities and in communities. Panelists derive informa-
tion from this mortality review process that informs their clin-
ical care and results in the potential for changes to practice—a 
secondary benefit that is challenging to measure.
Despite a standard approach to the DeCoDe process, there are 
inherent and preexisting site-to-site differences in data quality 
and quantity that introduce inconsistencies in the completeness 
of packet information available to panelists. In addition to the dif-
ferences in clinical care and diagnostic capabilities between sites, 
variations in the ways data are collected or recorded in clinical 
files—including by interviews of clinical staff or family– could lead 
to the introduction of bias. To help assess these potential sources 
of bias, the abstraction forms collect information on interviews 
that occurred and whether the person completing the abstraction 
was involved in the clinical care of the patient. At the panel meet-
ings, panelists who recall that they were involved in the care of a 
case disclose this to their colleagues. Given limitations in clinical 
documentation, the benefit of additional information and insights 
from these sources outweighs the risk of potential bias.
Elucidating the precise causal pathway and inciting 
condition(s) or event from single point-in-time results is chal-
lenging. While clinical records can be helpful, these records 
vary widely in their availability, quality, and completeness. 
Furthermore, patient management and standards of care differ 
across sites, and the cascade of events leading to death is often 
intertwined with the local context, care system, and standard of 
care. This inseparability of cause of death from context under-
score the essential role of local perspective in accurate deter-
mination of cause of death. However, panelists’ application of 
local knowledge and insight that is not reflected in data pack-
ages can decrease reproducibility of results achieved through 
the CHAMPS quality assurance process and external review. 
To address this challenge in reproducibility of results and to 
capture context-specific knowledge applied by the panel and 
not captured in data packages, panelists are asked to document 
any additional information considered on their final cause of 
death determination form. Local panelists are likely to un-
derstand more completely the cases’ clinical and epidemio-
logic contexts, to have ownership of their local case data and 
results, and to apply knowledge from the panel process more 
quickly—a justification for CHAMPS’ centrally supported and 
standardized but fundamentally site-specific DeCoDe process.
CHAMPS will continue to refine its methods to strengthen 
quality of conclusions and promote standardization. Nonetheless, 
the availability of postmortem pathology and laboratory data, 
added to verbal autopsy and available clinical data, has made it 
possible to precisely characterize actionable causes [15] and con-
tributors to childhood mortality to a degree that is likely orders 
of magnitude greater than what was previously available.
CONCLUSIONS
CHAMPS designed a robust process for determination of cause 
of death for longitudinal surveillance in multiple sites following 
principles from other child mortality review processes. These 
include the use of multidisciplinary expert panel review, stand-
ardized systems for data collection, management, curation, 
and review; development and implementation of specific diag-
nosis standards; structured approach to panel deliberation with 
standard forms; and use of already existing international and 
universally accepted standards for classification and coding of 
cases. Future analyses of DeCoDe panel outcomes and structured 
key informant interviews with panelists can reveal the extent to 
which the process achieves its objective of standardized cause of 
death determination in addition to fostering discussion on sys-
tems deficits and promoting action to reduce child mortality.
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